Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection is a GLP-1 receptor agonist originally developed for type 2 diabetes that has shown remarkable results for weight management, with clinical trials demonstrating average weight loss of 15–22% over 68 weeks. Understanding how dosing works and what happens during your treatment journey helps you set realistic expectations and stay committed to your health goals. This guide explains the typical dosing schedule, how your body responds, and why PlexusDx's flat-price model removes barriers to accessing the exact dose you need.

How Semaglutide Injection Dosing Begins

Semaglutide treatment starts with a very low introductory dose to allow your body time to adjust to the medication. The standard starting dose is 0.25 mg once weekly, which is well below the therapeutic range but primes your system to tolerate higher amounts. Most people don't feel dramatic effects at this dose level, which is intentional—your liver and metabolism are gently acclimating to the compound. The first injection marks the beginning of a 16–20 week titration schedule that steadily increases your weekly dose.

Your initial semaglutide shot is typically administered as a subcutaneous injection in your abdomen, thigh, or upper arm using a pen-style device. The needle is very fine (similar to insulin pen needles), and most patients report minimal discomfort. During week one, you'll receive just that single 0.25 mg dose, then remain on it for four weeks before your dose increases. This slow start reduces the likelihood of nausea or gastrointestinal side effects that can occur when the body hasn't fully adapted to GLP-1 activation.

The Four-Week Dose Escalation Schedule

After four weeks at 0.25 mg, your dose increases to 0.5 mg once weekly for the next four weeks. This doubling marks your first meaningful escalation and is when many patients begin noticing appetite suppression and improved blood sugar stability. Week nine brings your third dose increase to 1.0 mg weekly, which is often considered the maintenance threshold for weight loss. However, PlexusDx works with you to determine whether you benefit from continuing to climb toward the 2.4 mg maximum maintenance dose or stabilizing at a lower level that produces results with minimal side effects.

By weeks 13–16, patients who tolerate the medication well typically reach 1.7 mg or 2.4 mg weekly—the doses associated with the strongest clinical outcomes. The entire escalation process takes approximately 16–20 weeks, giving your body plenty of time to establish a new appetite set point and metabolic baseline. Throughout this titration, PlexusDx tracks your response through regular check-ins and genetic insights from the optional Precision Peptide Genetic Test, which maps 14 metabolic pathways to identify your individual response profile.

Maintaining Your Therapeutic Dose

Once you've reached your optimal dose—whether that's 0.5 mg, 1.0 mg, 1.7 mg, or 2.4 mg weekly—you'll continue receiving that same injection every seven days as long as you remain enrolled in treatment. There is no requirement to keep climbing; your dose remains stable at the level that delivers appetite suppression and weight loss without unacceptable side effects. Many successful patients find their sweet spot well below the maximum dose, meaning they experience excellent results with fewer gastrointestinal effects. The misconception that everyone must reach 2.4 mg often causes unnecessary anxiety; your provider adjusts based entirely on your clinical response, not a one-size-fits-all protocol.

PlexusDx's flat monthly pricing means your cost stays the same whether your maintenance dose is 0.5 mg or 2.4 mg. This removes the financial pressure to justify higher doses and lets you genuinely focus on the dose that works best for your body. Your monthly cost begins at $149 and remains predictable across all three commitment tiers, with no surprise increases as your dose changes. This pricing transparency ensures that accessing your optimal therapy never becomes an affordability barrier.

What Happens During Dose Increases

As your semaglutide dose increases each month, you may experience temporary adjustments in how you feel. Mild nausea, reduced appetite for foods you normally enjoy, and subtle changes in digestion are common during the first week after a dose increase. These effects typically diminish by the second or third week as your body acclimates, though some patients report persistent mild nausea that resolves with dietary adjustments like eating smaller, protein-rich meals. Staying hydrated and avoiding greasy or overly sweet foods accelerates the adjustment period.

Your weight loss often accelerates with each dose increase, though the pattern varies between individuals. Some patients see steady weekly progress, while others experience plateaus followed by sudden drops. This natural variation reflects how GLP-1 medications work—they reduce hunger and increase fullness signals, but your body also adjusts to hormonal changes over time. PlexusDx providers monitor your progress through monthly check-ins and can pause dose increases or add genetic insights via the Precision Peptide Genetic Test to optimize your metabolic pathway activation if weight loss slows unexpectedly.

Understanding Genetic Factors in Your Response

Not everyone responds identically to semaglutide, and part of that variation traces back to genetics. Key variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313) influence how strongly your body's hunger-regulating neurons respond to the medication. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 pathways across 49 peptides to identify your individual genetic predispositions. This information helps your provider predict whether you'll respond best to semaglutide alone, whether a dual-compound approach like GLP-Squared might suit you better, or whether a microdose protocol could deliver results with fewer side effects.

Understanding your genetic peptide profile transforms dosing from guesswork into precision medicine. A patient with favorable GLP1R activation may thrive at lower doses, while another with different genetic markers might reach therapeutic response only at higher doses. The test doesn't determine your dose directly—your clinical response always does—but it provides context for why your body behaves a certain way and whether adjusting your medication choice or formulation might improve your outcome. This personalized approach is what separates PlexusDx's model from standard weight loss clinics that treat all patients with the same protocol.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many shots of semaglutide do I receive in a typical month?

You receive one semaglutide injection per week, meaning four injections per month. During the initial 16–20 week dose escalation, your weekly dose increases every four weeks (so week 1–4 is 0.25 mg weekly, week 5–8 is 0.5 mg weekly, and so on). Once you reach your maintenance dose, you'll continue with one fixed dose per week indefinitely.

What clinical evidence supports the dosing schedule PlexusDx uses?

The four-week escalation schedule mirrors the STEP clinical trials conducted by Novo Nordisk, which demonstrated that gradual dose increases minimize nausea and gastrointestinal side effects while maintaining efficacy. Patients who completed the full titration to 2.4 mg achieved average weight loss of 15–22% over 68 weeks compared to placebo.

Does my monthly price increase if my dose goes up?

No. PlexusDx offers flat monthly pricing starting at $149 for semaglutide injection regardless of whether your maintenance dose is 0.5 mg or 2.4 mg. Your price remains the same across all three commitment tiers—the only change is your dose as your clinical response develops.

What are common side effects during dose increases?

Mild nausea and reduced appetite are most common during the week after a dose increase, usually resolving by week two or three. Constipation and reduced food tolerance also occur temporarily.

How does the Precision Peptide Genetic Test help with my semaglutide dosing?

The test identifies whether you carry genetic variants that enhance or reduce your response to GLP-1 activation, helping your provider predict your likely dose range and whether you might respond better to a different medication like tirzepatide.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves